The Ivy Brain Tumor Center was founded to provide new avenues of hope for patients and families struggling with aggressive brain tumors. Our philosophy is to deploy scientifically rigorous and technologically advanced clinical trials that rapidly evaluate new therapeutic regimens and are tailored to exploit and attack individual tumor biologies.
It is our mission is to increase life expectancy and contribute to a cure for malignant brain tumors by pioneering the largest, most advanced Phase 0 clinical trials program in the world. To achieve this goal, we invite patients and providers to submit a trials screening request and consider entry into our early-phase clinical trial program.
Scientific Advisory Board
Eric Holland, MD, PhD
Frank McCormick, PhD
Patricia LoRusso, DO
Susan Chang, MD
Benjamin Cravatt, PhD
The Ivy Brain Tumor Center research projects are administered by NeuroTrials, LLC, a non-profit limited liability company. NeuroTrials serves as a custodian of the research funds granted to the Center and is principally responsible for the Center’s scientific and clinical contracting, accounting, and project management. This unique organization enables unprecedented operational efficiency, fiscal transparency, and unbiased programmatic decision-making.